Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2026 Jan 30:17:1752143.
doi: 10.3389/fpsyt.2026.1752143. eCollection 2026.

fMRI-guided rTMS in the treatment of auditory verbal hallucinations in schizophrenia: a case report

Affiliations
Case Reports

fMRI-guided rTMS in the treatment of auditory verbal hallucinations in schizophrenia: a case report

Aykut Aytulun et al. Front Psychiatry. .

Abstract

Auditory verbal hallucinations (AVH) are a core symptom of schizophrenia and contribute substantially to patient suffering and disability. They are among the most persistent symptoms and do not respond to medication in a substantial portion of patients. Here, we report the application of task-based functional magnetic resonance imaging (fMRI)-guided repetitive transcranial magnetic stimulation (rTMS) in a patient with treatment-resistant AVH. An individualized stimulation target was identified in the left temporal cortex near Heschl's gyrus using a validated fMRI task. Over a period of 18 months, the patient underwent three cycles of inhibitory 1 Hz rTMS of this target. As a result, AVH severity decreased by 33% and the global symptom score improved by 40%. Functional connectivity analyses revealed an increase in coupling between the temporal target seed and a fronto-cingulate-insular network that has been implicated in reality and performance monitoring. This case highlights the potential of fMRI-guided rTMS as a personalized neuromodulatory therapy for refractory AVH in schizophrenia, warranting further systematic investigation.

Keywords: auditory verbal hallucinations; case report; fMRI; rTMS; schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors MC, DK, JL and LS declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Figures

Figure 1
Figure 1
TMS target location & neural correlates of ‘social localizer’ task across treatment. (A) Coronal, sagittal, and axial slices of the patient’s T1-weighted MRI overlaid with the individualized fMRI peak. The crosshair marks the MNI coordinate of the stimulation target (x = –49, y = 5, z = -1), located in the left temporal cortex near Heschl’s gyrus. (B) Surface-rendered statistical maps of task-related brain activation related to sound loudness during the ‘social localizer’ paradigm before the first (Pre) and between the 4. and 5. (Mid) session of the second rTMS cycle. Overlay of pre (in red) and mid (in blue) treatment, yellow indicating an overlap of activations. (C) Statistical maps of the individual sessions before and after treatment (p< 0.001, uncorrected).
Figure 2
Figure 2
Functional connectivity change across treatment. Functional connectivity of the Heschl’s Gyrus Seed. Brain maps depict regions that exhibited significantly lower FC (p847<10-6Bonferroni) before (Pre), compared with between 4. and 5. rTMS session (Mid; dark blue) or after (Post; mid blue) treatment and their overlap (light blue). Functional connectivity values of the clusters showing differences in at least two pairwise comparisons (Pre-Mid, Pre-Post, Mid-Post) are depicted by boxplots below the brain maps. CER, Cerebellum; INS, Insula; Str, Striatum; CG, Cingulate Gyrus; SFG, Superior Frontal Gyrus; MFG, Middle Frontal Gyrus; PrG, Precentral Gyrus.

References

    1. Sommer IEC, Slotema CW, Daskalakis ZJ, Derks EM, Blom JD, van der Gaag M. The treatment of hallucinations in schizophrenia spectrum disorders. Schizophr Bull. (2012) 38:704–14. doi: 10.1093/schbul/sbs034, PMID: - DOI - PMC - PubMed
    1. Köhler-Forsberg O, Madsen T, Behrendt-Møller I, Nordentoft M. The 10-year trajectories of auditory hallucinations among 496 patients with a first schizophrenia-spectrum disorder: Findings from the OPUS cohort. Schizophr Res. (2022) 243:385–91. doi: 10.1016/j.schres.2021.06.033, PMID: - DOI - PubMed
    1. Campana M, Falkai P, Siskind D, Hasan A, Wagner E. Characteristics and definitions of ultra-treatment-resistant schizophrenia – A systematic review and meta-analysis. Schizophr Res. (2021) 228:218–26. doi: 10.1016/j.schres.2020.12.002, PMID: - DOI - PubMed
    1. Siskind D, Siskind V, Kisely S. Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis. Can J Psychiatry Rev Can Psychiatr. (2017) 62:772–7. doi: 10.1177/0706743717718167, PMID: - DOI - PMC - PubMed
    1. Buck B, Munson J, Chander A, Wang W, Brenner CJ, Campbell AT, et al. The relationship between appraisals of auditory verbal hallucinations and real-time affect and social functioning. Schizophr Res. (2022) 250:112–9. doi: 10.1016/j.schres.2022.10.015, PMID: - DOI - PMC - PubMed

Publication types

LinkOut - more resources